Todd Rambasek is a Rheumatology/Immunology physician affiliated with Ohio University. OpenAlex indexes 10 publications with 259 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2800 Hayes Ave Bldg C
Sandusky, OH 448707251
Telephone
419-609-1800Registry record last updated 17 Mar 2018.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202520 payments$12,897openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202515 payments
- GlaxoSmithKline, LLC.Program year202527 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
95.7%Anti-IgE85.4%Omalizumab99%Xolair1%Part D + Part B<11 patientsCorticosteroid5%Fluticasone Propionate33%Trelegy Ellipta17%Breo Ellipta15%Arnuity Ellipta8%Budesonide-Formoterol Fumarate6%Symbicort6%Dulera5%Fluticasone Propionate Hfa3%Pulmicort Flexhaler3%Xhance3%Qvar Redihaler2%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
1.8%H2 blocker1%Famotidine100%Part D≥40 patientsProton pump inhibitor0.5%Omeprazole58%Pantoprazole Sodium42%Part D<11 patients+ 1 more class in this area
Dermatology
1.3%Interleukin-4 Receptor alpha Antagonist0.8%Dupixent Syringe55%Dupixent Pen45%Part D<11 patientsCorticosteroid0.5%Triamcinolone Acetonide100%Part D≥38 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis
The Journal of Allergy and Clinical Immunology In Practice
2019 - Omalizumab dosing via the recommended card versus use of the published formula
Journal of Allergy and Clinical Immunology
2006 - An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge model
Annals of Allergy Asthma & Immunology
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Matthew Zirwas, MD
Ohio University
Gary Cordingley, MD
Ohio University
Mitesh Parekh, MD
Ohio University
Vineeth Sukrithan, MD
Ohio University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”